Zoetis Inc.
Government Contracts & Awards
Proprietary Tech & Patents
FELINE ANTIBODY VARIANTS
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?
If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying replacements for older drugs losing exclusivity. Zoetis is cutting its effective price to keep the franchises it has. Same bet, two opposite defenses.
Tracking Tweedy Browne Portfolio - Q2 2026 Update
Tweedy Browneâs Q2 2026 13F: $1.32B portfolio, top holdings & new Zoetis stake, plus trims/exits and concentration insightsâread now.
Zoetis (NYSE:ZTS): Dividend Quality Backed by Strong Fundamentals
The Best Dividend Stocks screen identifies companies with strong dividends, profitability, and health. Zoetis (ZTS) stands out with a 1.64% yield, 20.56% dividend growth, and low payout ratio.
Zoetis: Sentiment Keeps Winning As Fundamentals Improve
Zoetis stock trades ~45% below fair value, despite resilient earnings, a low forward P/E, and a 2.8% dividend yield. Learn more. Click for more on ZTS stock.
Temporary Concerns Present Entry Point in Zoetis (ZTS)
Moon Capital Management, LLC, an investment management company, released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 index rebounded in the second quarter, achieving a 9.6% return for the first half of the year, while Moon Capital Management’s equity portfolio gained 4%. AI-related stocks led […]
Should You Continue to Hold PAHC Stock in Your Portfolio?
Phibro Animal Health gains from Animal Health strength and Zoetis MFA integration, but macro and FX headwinds remain as the stock rises 27.6% over the past year.
Congressional Trades in $ZTS
Insider Trades (Form 4)
PECK KRISTIN C
Esch Kevin
Driscoll Rimma
FULLER JULIE
Sarbaugh Keith
Ferran Astorga Jeannette
Nayak Abhay U
Lagano Roxanne
Key People
Stetter Mark
Director
SACCARO JAMES
EVP, CFO & COO
Joseph Wetteny
Chief Financial Officer
Driscoll Rimma
Executive Vice President
Nayak Abhay U
Executive Vice President
Esch Kevin
Executive Vice President
Sarbaugh Keith
Executive Vice President
PECK KRISTIN C
Chief Executive Officer
Ferran Astorga Jeannette
Executive Vice President
Lagano Roxanne
Executive Vice President
FULLER JULIE
Executive Vice President
MCCALLISTER MICHAEL B
Director
PARENT LOUISE M
Director
DAMELIO FRANK A
Director
Bisaro Paul
Director
Political Giving
$95,000 given to 19 candidates across 38 disclosed contributions (FEC Schedule A).
Hakeem S. Jeffries
Deb Fischer
Deborah K. Ross
John Hoeven
Markwayne Mullin
Tracey Robert Mann
Frank Pallone
Gary Peters
John Boozman
Mikie Sherrill
Thom Tillis
Adrian Smith
Katherine M. Clark
Bill Cassidy
John Fetterman
Rick Larsen
Pete Sessions
Kurt Schrader
John Cornyn
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro